Checkmark
WashingtonVotes.org
your lawmakers' votes at your fingertips
A free public service of Washington Policy Center
Legislation watch
     

Search all years.

2019 Senate Bill 5292: Concerning prescription drug cost transparency
Introduced by Sen. Karen Keiser (Kent) (D) on January 17, 2019
  Official Text and Analysis.
Referred to the Senate Health & Long-Term Care Committee on January 17, 2019
Substitute offered in the Senate on February 8, 2019
Requires issuers and drug manufacturers to report certain prescription drug pricing data on a yearly basis to the Office of Financial Management (OFM.
Referred to the Senate Ways & Means Committee on February 11, 2019
Substitute offered in the Senate on February 26, 2019
Requires issuers, carriers, pharmacy benefit managers, and pharmacy services administrative organizations to report certain prescription drug pricing data on a yearly basis to the Health Care Authority (HCA).
Referred to the Senate Rules Committee on February 28, 2019
Passed 49 to 0 in the Senate on February 28, 2019.
    See Who Voted "Yes" and Who Voted "No".
Received in the House on March 1, 2019
Referred to the House Health Care & Wellness Committee on March 1, 2019
Referred to the House Appropriations Committee on April 1, 2019